Increased telomerase activity and vitamin D supplementation in overweight African Americans

International Journal of Obesity

Volumn 36, Issue 6, 2012, Pages 805-809

  Zhu, H ^a   Guo, D ^a   Li, K ^b   Pedersen White, J ^a   Stallmann Jorgensen, I S ^a   Huang, Y ^a   Parikh, S ^a   Liu, K ^a   Dong, Y ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b WUHAN UNIVERSITY   (China)

Author keywords

25(OH)D; African Americans; telomerase activity; vitamin D supplementation

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; COLECALCIFEROL; PARATHYROID HORMONE; PLACEBO; TELOMERASE; VITAMIN D;

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; ARTICLE; BODY MASS; CELL AGING; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; GENE AMPLIFICATION; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; OBESITY; OUTCOME ASSESSMENT; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; VITAMIN SUPPLEMENTATION;

ADULT; AFRICAN AMERICANS; ANALYSIS OF VARIANCE; CHOLECALCIFEROL; CROSS-SECTIONAL STUDIES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; OBESITY; TELOMERASE; TREATMENT OUTCOME; VITAMIN D;

EID: 84862226721     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2011.197     Document Type: Article

References (52)

1. Valdes AM, Andrew T, Gardner JP, Kimura M, Oelsner E, Cherkas LF et al. Obesity, cigarette smoking, and telomere length in women. Lancet 2005; 366: 662-664. (Pubitemid 41176019)
2. Gardner JP, Li S, Srinivasan SR, Chen W, Kimura M, Lu X et al. Rise in insulin resistance is associated with escalated telomere attrition. Circulation 2005; 111: 2171-2177. (Pubitemid 40632431)
3. Kim S, Parks CG, DeRoo LA, Chen H, Taylor JA, Cawthon RM et al. Obesity and weight gain in adulthood and telomere length. Cancer Epidemiol Biomarkers Prev 2009; 18: 816-820.
4. Lee M, Martin H, Firpo MA, Demerath EW. Inverse association between adiposity and telomere length: The Fels Longitudinal Study. Am J Hum Biol 2011; 23: 100-106
5. Dagarag M, Evazyan T, Rao N, Effros RB. Genetic manipulation of telomerase in HIV-specific CD8+ T cells: enhanced antiviral functions accompany the increased proliferative potential and telomere length stabilization. J Immunol 2004; 173: 6303-6311. (Pubitemid 39487789)
6. Fauce SR, Jamieson BD, Chin AC, Mitsuyasu RT, Parish ST, Ng HL et al. Telomerasebased pharmacologic enhancement of antiviral function of human CD8+ T lymphocytes. J Immunol 2008; 181: 7400-7406.
7. Effros RB. Telomere/telomerase dynamics within the human immune system: effect of chronic infection and stress. Exp Gerontol 2011; 46: 135-140.
8. Weng NP, Granger L, Hodes RJ. Telomere lengthening and telomerase activation during human B cell differentiation. Proc Natl Acad Sci USA 1997; 94: 10827-10832. (Pubitemid 27430820)
9. Perez-Rivero G, Ruiz-Torres MP, Rivas-Elena JV, Jerkic M, Diez-Marques ML, Lopez-Novoa JM et al. Mice deficient in telomerase activity develop hypertension because of an excess of endothelin production. Circulation 2006; 114: 309-317. (Pubitemid 44297097)
10. Imanishi T, Moriwaki C, Hano T, Nishio I. Endothelial progenitor cell senescence is accelerated in both experimental hypertensive rats and patients with essential hypertension. J Hypertens 2005; 23: 1831-1837. (Pubitemid 41830423)
11. Leri A, Franco S, Zacheo A, Barlucchi L, Chimenti S, Limana F et al. Ablation of telomerase and telomere loss leads to cardiac dilatation and heart failure associated with p53 upregulation. EMBO J 2003; 22: 131-139. (Pubitemid 36091276)
12. Franco S, Segura I, Riese HH, Blasco MA. Decreased B16F10 melanoma growth and impaired vascularization in telomerase-deficient mice with critically short telomeres. Cancer Res 2002; 62: 552-559. (Pubitemid 34106431)
13. Kuhlow D, Florian S, von Figura G, Weimer S, Schulz N, Petzke KJ et al. Telomerase deficiency impairs glucose metabolism and insulin secretion. Aging 2010; 2: 650-658
14. Wolkowitz OM, Mellon SH, Epel ES, Lin J, Reus VI, Rosser R et al. Resting leukocyte telomerase activity is elevated in major depression and predicts treatment response. Mol Psychiatry 2011; e-pub ahead of print 18 January 2011.
15. Epel ES, Lin J, Wilhelm FH, Wolkowitz OM, Cawthon R, Adler NE et al. Cell aging in relation to stress arousal and cardiovascular disease risk factors. Psychoneuroendocrinology 2006; 31: 277-287. (Pubitemid 43261645)
16. Farzaneh-Far R, Lin J, Epel ES, Harris WS, Blackburn EH, Whooley MA. Association of marine omega-3 fatty acid levels with telomeric aging in patients with coronary heart disease. JAMA 2010; 303: 250-257.
17. Ornish D, Lin J, Daubenmier J, Weidner G, Epel E, Kemp C et al. Increased telomerase activity and comprehensive lifestyle changes: a pilot study. Lancet Oncol 2008; 9: 1048-1057.
18. Veldman CM, Cantorna MT, DeLuca HF. Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. Arch Biochem Biophys 2000; 374: 334-348.
19. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-281.
20. Lee JH, O'Keefe JH, Bell D, Hensrud DD, Holick MF. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol 2008; 52: 1949-1956.
21. Grant WB, Peiris AN. Possible role of serum 25-hydroxyvitamin D in black-white health disparities in the United States. J Am Med Dir Assoc 2010; 11: 617-628.
22. Gouni-Berthold I, Krone W, Berthold HK. Vitamin D and cardiovascular disease. Curr Vasc Pharmacol 2009; 7: 414-422.
23. Reddy Vanga S, Good M, Howard PA, Vacek JL. Role of vitamin D in cardiovascular health. Am J Cardiol 2010; 106: 798-805.
24. Ginde AA, Scragg R, Schwartz RS, Camargo Jr CA. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U. S. adults. J Am Geriatr Soc 2009; 57: 1595-1603.
25. Semba RD, Houston DK, Bandinelli S, Sun K, Cherubini A, Cappola AR et al. Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults. Eur J Clin Nutr 2010; 64:
26. Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B et al. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med 2008; 168: 1340-1349. (Pubitemid 351930842)
27. Dong Y, Stallmann-Jorgensen IS, Pollock NK, Harris RA, Keeton D, Huang Y et al. A 16-week randomized clinical trial of 2000 international units daily vitamin D3 supplementation in black youth: 25-hydroxyvitamin D, adiposity, and arterial stiffness. J Clin Endocrinol Metab 2010; 95: 4584-4591.
28. Harris RA, Pedersen-White J, Guo DH, Stallmann-Jorgensen IS, Keeton D, Huang Y et al. Vitamin D(3) Supplementation for 16 Weeks Improves Flow-Mediated Dilation in Overweight African-American Adults. Am J Hypertens 2011; 24: 557-562
29. Richards JB, Valdes AM, Gardner JP, Paximadas D, Kimura M, Nessa A et al. Higher serum vitamin D concentrations are associated with longer leukocyte telomere length in women. Am J Clin Nutr 2007; 86: 1420-1425. (Pubitemid 350126247)
30. Yates AA, Schlicker SA, Suitor CW. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D and fluoride. J Am Diet Assoc 1998; 98: 699-706
31. Kapuku GK, Treiber FA, Davis HC, Harshfield GA, Cook BB, Mensah GA. Hemodynamic function at rest, during acute stress, and in the field: predictors of cardiac structure and function 2 2 years later in youth. Hypertension 1999; 34: 1026-1031.
32. Cohen-Lahav M, Shany S, Tobvin D, Chaimovitz C, Douvdevani A. Vitamin D decreases NFkappaB activity by increasing IkappaBalpha levels. Nephrol Dial Transplant 2006; 21: 889-897.
33. Cohen-Lahav M, Douvdevani A, Chaimovitz C, Shany S. The anti-inflammatory activity of 1,25-dihydroxyvitamin D3 in macrophages. J Steroid Biochem Mol Biol 2007; 103: 558-562.
34. Eleftheriadis T, Antoniadi G, Liakopoulos V, Kartsios C, Stefanidis I, Galaktidou G. Paricalcitol reduces basal and lipopolysaccharide-induced (LPS) TNF-alpha and IL-8 production by human peripheral blood mononuclear cells. Int Urol Nephrol 2010; 42: 181-185.
35. Zhang X, Zanello LP. Vitamin D receptor-dependent 1 alpha,25(OH)2 vitamin D3-induced anti-apoptotic PI3K/AKT signaling in osteoblasts. J Bone Miner Res 2008; 23: 1238-1248. (Pubitemid 352040178)
36. Kang SS, Kwon T, Kwon DY, Do SI. Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit. J Biol Chem 1999; 274: 13085-13090.
37. Xia L, Wang XX, Hu XS, Guo XG, Shang YP, Chen HJ et al. Resveratrol reduces endothelial progenitor cells senescence through augmentation of telomerase activity by Akt-dependent mechanisms. Br J Pharmacol 2008; 155: 387-394.
38. Junhui Z, Xiaojing H, Binquan Z, Xudong X, Junzhu C, Guosheng F. Nicotinereduced endothelial progenitor cell senescence through augmentation of telomerase activity via the PI3K/Akt pathway. Cytotherapy 2009; 11: 485-491
39. Sarin KY, Cheung P, Gilison D, Lee E, Tennen RI, Wang E et al. Conditional telomerase induction causes proliferation of hair follicle stem cells. Nature 2005; 436: 1048-1052. (Pubitemid 41191691)
40. Park JI, Venteicher AS, Hong JY, Choi J, Jun S, Shkreli M et al. Telomerase modulates Wnt signalling by association with target gene chromatin. Nature 2009; 460: 66-72.
41. Kovalenko OA, Caron MJ, Ulema P, Medrano C, Thomas AP, Kimura M et al. A mutant telomerase defective in nuclear-cytoplasmic shuttling fails to immortalize cells and is associated with mitochondrial dysfunction. Aging Cell 2010; 9: 203-219.
42. Zhu J, Wang H, Bishop JM, Blackburn EH. Telomerase extends the lifespan of virustransformed human cells without net telomere lengthening. Proc Natl Acad Sci USA 1999; 96: 3723-3728. (Pubitemid 29168977)
43. Provvedini DM, Tsoukas CD, Deftos LJ, Manolagas SC. 1,25-dihydroxyvitamin D3 receptors in human leukocytes. Science 1983; 221: 1181-1183.
44. Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF, O0Garra A. 1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol 2001; 167: 4974-4980. (Pubitemid 33009728)
45. Barrat FJ, Cua DJ, Boonstra A, Richards DF, Crain C, Savelkoul HF et al. In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)-and Th2-inducing cytokines. J Exp Med 2002; 195: 603-616. (Pubitemid 34461505)
46. Palmer MT, Lee YK, Maynard CL, Oliver JR, Bikle DD, Jetten AM et al. Lineagespecific effects of 1,25-dihydroxyvitamin D(3) on the development of effector CD4 T cells. J Biol Chem 2011; 286: 997-1004.
47. Lysandropoulos AP, Jaquiery E, Jilek S, Pantaleo G, Schluep M, Du Pasquier RA. Vitamin D has a direct immunomodulatory effect on CD8+ T cells of patients with early multiple sclerosis and healthy control subjects. J Neuroimmunol 2011; 233: 240-244
48. Valenzuela HF, Effros RB. Divergent telomerase and CD28 expression patterns in human CD4 and CD8 T cells following repeated encounters with the same antigenic stimulus. Clin Immunol 2002; 105: 117-125. (Pubitemid 35471660)
49. Wang L, Manson JE, Song Y, Sesso HD. Systematic review: Vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med 2010; 152: 315-323.
50. Geleijnse JM. Vitamin D and the prevention of hypertension and cardiovascular diseases: a review of the current evidence. Am J Hypertens 2010; 24: 253-262.
51. Jaskelioff M, Muller FL, Paik JH, Thomas E, Jiang S, Adams AC et al. Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice. Nature 2011; 469: 102-106.
52. Tsirpanlis G, Chatzipanagiotou S, Boufidou F, Kordinas V, Zoga M, Alevyzaki F et al. Serum oxidized low-density lipoprotein is inversely correlated to telomerase activity in peripheral blood mononuclear cells of haemodialysis patients. Nephrology (Carlton) 2006; 11: 506-509. (Pubitemid 44951231)